Teva Pharmaceutical Industries (TEVJF) Prepaid Assets (2009 - 2026)
Teva Pharmaceutical Industries (TEVJF) recorded quarterly Prepaid Assets of $535.0 million in Q1 2026, down 52.32% on a QoQ basis from $1.1 billion in Q4 2025, and down 47.45% year-over-year from $1.0 billion in Q1 2025.
Teva Pharmaceutical Industries (TEVJF) Prepaid Assets (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries has disclosed Prepaid Assets across 11 years of filings, most recently posting $535.0 million for Q1 2026.
- Quarterly Prepaid Assets fell 47.45% year-over-year to $535.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $535.0 million (down 47.45% YoY) and the FY2025 annual result came in at $1.1 billion, up 174.33% from the prior year.
- Prepaid Assets declined to $535.0 million in Q1 2026, from $1.1 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.3 billion in Q1 2024 and troughed at $409.0 million in Q4 2024.
- A 5-year average of $836.2 million and a median of $933.0 million in 2022 frame the typical range for Prepaid Assets.
- Biggest YoY gain for Prepaid Assets was 174.33% in 2025; the steepest drop was 56.93% in 2025.
- Tracing TEVJF's Prepaid Assets over 5 years: stood at $1.2 billion in 2022, then plunged by 56.63% to $504.0 million in 2023, then decreased by 18.85% to $409.0 million in 2024, then jumped by 174.33% to $1.1 billion in 2025, then sank by 52.32% to $535.0 million in 2026.
- Business Quant data shows TEVJF's Prepaid Assets at $535.0 million in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Teva Pharmaceutical Industries | - | - | 1.97 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.00 Mn |
| Dec 31, 2025 | 1.12 Bn |
| Sep 30, 2025 | 1.12 Bn |
| Jun 30, 2025 | 472.00 Mn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 409.00 Mn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.10 Bn |
| Mar 31, 2024 | 1.34 Bn |
| Dec 31, 2023 | 504.00 Mn |
| Sep 30, 2023 | 520.00 Mn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 542.00 Mn |
| Dec 31, 2022 | 1.16 Bn |
| Sep 30, 2022 | 579.00 Mn |
| Jun 30, 2022 | 518.00 Mn |
| Mar 31, 2022 | 933.00 Mn |
| Dec 31, 2021 | 1.08 Bn |
| Sep 30, 2021 | 1.07 Bn |
| Jun 30, 2021 | 1.02 Bn |